Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Forward Dividend Yield % : 0.00% (As of May. 28, 2025)

View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Forward Dividend Yield %?

As of today (2025-05-28), the Forward Annual Dividend Yield of Jiangsu Lianhuan Pharmaceutical Co is 0.00%.

As of today (2025-05-28), the Trailing Annual Dividend Yield of Jiangsu Lianhuan Pharmaceutical Co is 1.60%.

SHSE:600513's Forward Dividend Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.785
* Ranked among companies with meaningful Forward Dividend Yield % only.

Jiangsu Lianhuan Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

During the past 3 years, the average Dividends Per Share Growth Rate was 11.60% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 15.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 14.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Jiangsu Lianhuan Pharmaceutical Co was 65.10% per year. The lowest was -17.00% per year. And the median was 15.20% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Jiangsu Lianhuan Pharmaceutical Co's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Lianhuan Pharmaceutical Co's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's Forward Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Jiangsu Lianhuan Pharmaceutical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Jiangsu Lianhuan Pharmaceutical Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Lianhuan Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Forward Dividend Yield %

Traded in Other Exchanges

N/A

Address

No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127

Website

http://www.lhpharma.com

Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).

Executives

Wang Chun Yuan	Supervisors
Chu Qing Song	senior management
Xia Chun Lai	Director
Pan He Ping	Directors, senior managers
Niu Ben	senior management
Wu Wen Ge	Director
Zhu Yong Jun	senior management
Qian Zhen Hua	Director
Shen Yi	senior management
Huang Wen Tao	senior management
Zhou Jun	senior management
Tu Bin	senior management
Qin Xiong Jian	senior management

Jiangsu Lianhuan Pharmaceutical Co Headlines

No Headlines